[DOI] [PubMed] [Google Scholar] 24.Yajnik CS, Lubree HG, Thuse NV, Ramdas LV, Deshpande SS, Deshpande VU, Deshpande JA, Uradey BS, Ganpule AA, Naik SS, et al
A spate of small molecules that inhibited OGA ( O-GlcNAcase ), an enzyme that modifies tau, have also failed in recent years
The peptide has regulatory approval in over 30 countries for conditions including hepatitis B and C, where it is used as an immune enhancer
EXP: 12/2027 - 03/2028
It may promote tissue repair, support blood vessel growth, reduce inflammation, and aid muscle, tendon, and ligament recovery
Approximately 10% of Caucasians and African Americans are heterozygous, conferring intermediate TPMT activity